Takuya Miyano

Takuya Miyano

Daiichi-Sankyo Co., Ltd - Tokyo / Japan
Medical and Health Sciences / Pharmacology
AD Scientific Index ID: 4560462
person_outline Takuya Miyano's MOST POPULAR ARTICLES
1-) Anionic amino acid dendrimer− trastuzumab conjugates for specific internalization in HER2-positive cancer cellsT Miyano, W Wijagkanalan, S Kawakami, F Yamashita, M HashidaMolecular pharmaceutics 7 (4), 1318-1327, 2010712010
2-) Decision support method for the choice between batch and continuous technologies in solid drug product manufacturingK Matsunami, T Miyano, H Arai, H Nakagawa, M Hirao, H SugiyamaIndustrial & Engineering Chemistry Research 57 (30), 9798-9809, 2018442018
3-) Verification of model development technique for NIR-based real-time monitoring of ingredient concentration during blendingH Nakagawa, M Kano, S Hasebe, T Miyano, T Watanabe, N WakiyamaInternational journal of pharmaceutics 471 (1-2), 264-275, 2014282014
4-) Establishment of a clinically relevant specification for dissolution testing using physiologically based pharmacokinetic (PBPK) modeling approachesT Kato, H Nakagawa, T Mikkaichi, T Miyano, Y Matsumoto, S AndoEuropean Journal of Pharmaceutics and Biopharmaceutics 151, 45-52, 2020302020
5-) A mathematical model to identify optimal combinations of drug targets for dupilumab poor responders in atopic dermatitisT Miyano, AD Irvine, RJ TanakaAllergy 77 (2), 582-594, 2022232022